$9.43
-0.13 (-1.36%)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
CAPS Rating:
The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.
RSS Headlines
Fool UK